Correlation between integrin alpha 5 expression and the malignant phenotype of transitional cell carcinoma. by Saito, T. et al.
British Journal of Cancer (1996) 73, 327-331
© 1996 Stockton Press All rights reserved 0007-0920/96 $12.00 0
Correlation between integrin x5 expression and the malignant phenotype of
transitional cell carcinoma
T Saito, M Kimura, T Kawasaki, S Sato and Y Tomita
Department of Urology, Niigata University School ofMedicine, Asahimachi 1, Niigata 951, Japan.
Summary We examined the expression of al, a2, a3, a4, a5 and ,B1 integrin on 36 transitional cell cancers
(TCCs) in the bladder by immunohistochemistry. Only a2, a3 and /31 were detected on normal transitional cell
epithelium, but four TCCs (12.5%) revealed positive staining for al, seven (19.4%) for a4 and seven (20%) for
a5. These altered expressions of integrin a chain were more frequent in histologically higher stage or grade of
TCC, and a correlation was found between increased aS expression and histological stage. ae5 was positive in 6
(35.3%) of 17 invasive TCCs whereas only 1 (5.9%) of 17 superficial TCCs. Flow cytometric analysis on
bladder cancer cell lines showed that T24 and HT1376, which are undifferentiated TCC cell lines, highly
expressed aS and P1. Also, SCaBER, which is derived from urinary bladder squamous cell cancer and which is
recognised as the most malignant phenotype after metaplasia of transitional epithelium, had aS and P1.
However, RT4, which is derived from transitional cell papilloma, showed no expression of a5. Furthermore,
reverse transcriptase-polymerase chain reaction (RT-PCR) showed the presence of mRNA of aS on T24,
SCaBER and HT1376, but not on RT4. Taken together, it seems that the presence of axS integrin might be a
more malignant phenotype in transitional cell carcinoma.
Keywords: integrin; VLA-5; transitional cell cancer; immunohistochemistry; flow cytometry; reverse
transcriptase-polymerase chain reaction
In the process of tumour invasion and metastasis, the
interaction between tumour cells and extracellular matrix
(ECM), such as laminin, fibronectin and collagens, has a
crucial role (Nicolson and Winkelmake, 1975; Horn and
Tang, 1992). This interaction is facilitated through adhesion
receptors such as integrins. Integrins are a family of cell-
surface proteins that mediate cell adhesion to ECM and
signal transduction to the cell interior (Hynes, 1990; Albelda,
1993). They are composed of two subunits, a and ,B, each of
which spans the plasma membrane. Distinct a-subunits
combine with common or related fl-subunits to form
functionally distinct receptors.
Integrin distributions have been studied in a number of
tissues, including malignant tumours. Recent studies showed
that patterns of integrin expression on tumour cells were
different compared with normal counterparts and suggested
that altered integrin expression may contribute to the invasive
or metastatic phenotype. For example, the loss of integrin
expression was reported in epithelial neoplasms, such as
carcinomas of the breast, colon, pancreas and skin (Pignatelli
et al., 1990; Zutter et al., 1990; Hall et al., 1991; Stamp and
Pignatelli, 1991). On the other hand, up-regulation of aV#3
was described in malignant melanoma and glioblastoma
multiforme, and acquisition of a4#1 has been described in
malignant melanoma and renal cell carcinoma (Cheresh et al.,
1989; Gladson and Cheresh, 1991; Tomita et al., 1995). In
transitional cell carcinoma (TCC), progressive loss of a2
integrin expression from normal urothelial cells through
invasive cancers was reported and some a5 integrin was
expressed on high stage TCC (Leibert et al., 1994).
VLA-5 (a5fl1 integrin) is a fibronectin receptor whose
expression is often reduced in tumour cells (Plantefaber and
Hynes, 1989). In addition, increasing theexpression ofthea5,Bf
integrin by gene transfer decreases the formation oftumours on
Chinese hamster ovary cells, suggesting the presence ofVLA-5
on tumour cells might be a disadvantage for their proliferation
(Giancotti and Ruoslahti, 1990). Indeed, after transfection,
they showed less migratory, reacquired features of normal
growth control in culture, resulting in lost ability to form
tumours when injected subcutaneously into nude mice
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(Giancotti and Ruoslahti, 1990). Several other studies,
including some on human tumour cells, confirmed the
correlation between low VLA-5 expression and malignant
transformation or higher malignant potential (Varner et al.,
1992; Witkowski et al., 1993).
The expression of VLA-5 on high stage TCC in a previous
report seemed curious. Therefore, we focused our interest on
the expression of VLA-5 on TCC and the normal transitional
cell and its mRNA. We examined the expression of integrins
on 36 TCCs and six normal transitional cells by immunohis-
tochemistry. Flow cytometric analysis and RT-PCR for
VLA-5 or mRNA of x5 integrin on bladder cancer cell lines
and normal transitional cell line were also performed. We
showed that the presence of VLA-5 might indicate a more
malignant phenotype, as for TCC.
Materials and methods
Tissue specimens
Tumour specimens were obtained from 36 patients (25 males
and 11 females) who had undergone total cystectomy or
transurethral resection for bladder cancer. The mean age at
the time of operation was 67.9 years, ranging from 41 to 84
years. Six specimens of normal urinary bladder epithelium
were collected from a histologically unaffected portion of the
bladder. Tissue samples were embedded in an optimum cold
temperature compound (Miles Laboratories, Naperville, IL,
USA) and were quickly frozen in isopentane, precooled in
dry ice acetone. These blocks were stored at -80°C until
5 gm serial sections were cut using a cryostat. Histological
examination was performed on haematoxylin and eosin-
stained tissue sections. Tumours were graded and staged
according to the criteria of the World Health Organization.
Reagents
Monoclonal antibodies (MAbs) used in this study were as
follows: TS2/7 against axl, P1E6 against cx2, PlB5 against a3,
P4G9 against x4, P1D6 against a5, 4B4 against #1.
Polyclonal anti-a5 antibody AB1928 was also used. These
MAbs were purchased from Telious Pharmaceuticals (San
Diego, CA, USA), except for 4B4 which was purchased from
Corter (Hialeah, FL, USA) and AB1928, which wasIntegrin and transitional cell carcinoma
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purchased from Chemicon International (Temecula, CA,
USA). Optimal dilution for each antibody was determined
by staining specimens of lymph nodes obtained during
nephrectomy for renal cell carcinoma without tumour
metastasis.
Immunoperoxidase staining
Immunoperoxidase staining was performed using the
streptavidin-biotin bridge technique as described previously
(Tomita et al., 1990). Briefly, serial sections were air dried
and fixed in cold acetone. After rehydration with phosphate-
buffered saline (PBS), sections were incubated in PBS
containing 20% normal sheep serum (Antibodies, Davis,
CA, USA) for 30 min, and endogenous biotin was blocked
using an endogenous biotin blocking kit (Vector Labora-
tories, Burlingame, CA, USA). They were then incubated
with mouse MAbs for 60 min, followed by incubation with
biotinylated sheep anti-mouse immunoglobulin (Amersham
International, Amersham, Bucks, UK) in PBS containing
20% human type AB serum (Biological Speciality, Lansdale,
PA). Subsequently, they were incubated with streptavidin-
peroxidase (Amersham) for 15 min. Each step was followed
by washing in PBS with three changes of buffer. Finally, the
sections were immersed in 0.05 mol 1-l Tris-HCl buffer
containing 0.05% diaminobenzene and 0.01% hydrogen
peroxide for 4-20 min to visualise the reaction products.
Specimens were counterstained in Meayer's haematoxylin and
mounted after dehydrating in graded ethanol and xylene.
Tumours were considered as positive when positive tumour
cells were observed in the specimen, although the tumour
tissue showed various staining pattern when reacted with
anti-a5 MAb. Statistical analysis was done by using the chi-
square test.
Flow cytometric analysis of bladder cancer cell lines
To investigate differences in a5 expression among bladder
cancer cell lines with various characteristics, we used four
established bladder cancer cell lines and a normal transitional
cell line obtained from the American Type Culture Collection
(ATCC). Three cancer cell lines, T24 (Bubenik et al., 1973),
SCaBER (O'Toole et al., 1976) and HT1376 (Rasheed et al.,
1977) were derived from high-grade bladder cancers; one,
RT4 (Rigby and Franks, 1970), was derived from papilloma
and HTB160 was derived from normal fetal bladder cells.
These cell lines were cultured in 3055 (Coaster, CA, USA)
25 cm2 tissue culture flasks in complete medium (RPMI-1640
medium containing 10% fetal calf serum). For flow
cytometric analysis, cells were stained by the indirect
immunofluorescence method as described previously (Tomi-
ta et al., 1990). Briefly, tumour cell suspensions were
prepared by treatment with 0.125% trypsin and 0.02%
EDTA. Tumour cells were reacted with anti-a5 or PI MAb
in PBS supplemented with 2% fetal calf serum and 0.02%
sodium azide for 30 min at 4°C. After washing twice by
centrifugation, cells were incubated with fluorescein isothio-
cyanate-conjugated goat anti-mouse Ig (Tago, Burlingame,
CA, USA) for 30 min at 4°C. Subsequently, the cells were
washed three times and analysed by flow cytometry
(FACScan, Becton-Dickinson).
Reverse transcription of RNA followed by the polymerase
chain reaction (RT-PCR) analysis
Total RNA was isolated from cell lines using RNAzol
(Biotecx Laboratories, USA) according to the instructions of
the manufacturers. Total RNA (10 ,ug) was used for cDNA
synthesis. First-strand cDNA solution (2 Mil) was then used
for PCR, with primers designed to amplify a 1421 bp a5
cDNA sequence from bp 1625 to bp 3046 (sense primer
sequence: 5'-AACAGGATGGCTAGGATGAT, antisense
primer sequence: 5'-ACAAGTTGCTGACTCCATTG). PCR
was performed in 50 ,ul buffer (50 mmol 1-1 potassium
chloride; 10 mmol 1-1 Tris-HCl, pH 8.4; 1.5 mmol I`
magnesium chloride and 200 mg ml-' gelatin), with
200 mmol 1-1 of each dNTP, 2.5 mmol 1` of each oligonu-
cleotide primer, and 2.5 U of Taq DNA polymerase
(Boehringer Mannheim, Germany). Thirty-five cycles of
1 min denaturation at 94°C, 1 min annealing at 60°C, and a
1.5 min extension step at 72°C were performed. At the end of
the 35 cycles, an additional 10 min extension step at 72°C
was added. Subsequently, to confirm the specificity of this
product, nested PCR was performed using 5 ,ul of PCR
product with primers designed to amplify a 1268 bp a5
cDNA sequence from bp 1657 to bp 2925 (sense primer
sequence: 5'-TCAGGGATCCAACTTCAGCTGGACTGG-
CAGAAGCA, antisense primer sequence: 5'-GATC-
GAATTCGGGCATCTTCAGGGCTTTGTACACA).
Results
In situ expressions of integrins on TCCs
When normal transitional cells were stained with anti-integrin
MAbs, constitutional expressions of a2, a3 and P1I were
detected. However, al, a4 and a5 were negative for all six
normal transitional cell specimens. On the contrary, four
TCCs (12.5%) revealed positive staining for al, 7 (19.4%) for
a4 and 7 (20%) for a5 (Figure 1). Three TCCs (8.3%)
showed decreased expression of a2. These altered expressions
ofintegrin a chain were more frequent in histologically higher
stage or higher grade ofTCC (Table I). Although statistically
not significant, a correlation was found between increased aS
expression and the histological stages. a5 was positive in 6
(35.3%) of 17 invasive TCCs but only 1 (5.9%) of 17
superficial TCCs (Table II).
a
b
Figure 1 Immunohistochemical staining for a5 integrin. (a)
Grade 3 invasive (pT4) bladder TCC positively stained with
anti-a5 integrin. (b) Grade 1 non-invasive (pTl) bladder TCC was
negative for a5. Scale bars=751im.
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Table I Clinical and histological features and expression of integrins on TCC
No. Age Sex T-stage Grade ad a2 3 oa4 aS ,B1
1 62 M 2 2 - + + - +
2 52 M 4 3 - + + + +
3 59 M 1 2 - + + +
4 58 M 1 2 - + + - - +
5 72 F 1 3 - + + - - +
6 73 M 4 3 - + + - - +
7 65 M 3 3 - + + - - +
8 62 M 2 3 - + + - - +
9 73 M 3 3 - + + + - +
10 74 M 1 3 + + + + - +
11 69 F 3 2 - + + - ND +
12 67 F 3 3 - + + - + +
13 79 M 4 3 - + + - - +
14 70 M 1 3 - + + - - +
15 60 M 4 3 - + + + +
16 72 M 2 3 - + + - - +
17 72 F 1 3 - + + - - +
18 67 F 2 2 - + + - - +
19 72 M 1 2 - + + - - +
20 60 F 3 3 + + + - + +
21 41 M 2 2 - - + + + +
22 76 F 3 3 - + + - + +
23 77 M 4 2 - + + - + +
24 72 M 2 2 - + + - +
25 75 M 3 3 + + + - + +
26 76 M 1 2 - + + + - +
27 65 F 1 3 + + + - +
28 41 F 1 2 + + +
29 74 M 1 3 - + - - +
30 68 M 1 2 - + + - - +
31 58 M 1 1 + + +
32 68 M 1 1 + + + - + +
33 69 F a 1 ND + + - - +
34 84 M 1 1 ND + + - - +
35 82 M a 1 ND + + - - +
36 82 F 1 2 ND + + - - +
-, Negative; +, positive; ND, not done
Table II Correlation between a5 expression on bladder cancer and
T-stage
aS expression on TCC
_ ~~~+
Ta, TI 16 1
T2-T4 11 6
Flow cytometric analysis of the expression of a5 and /3I
integrins on human TCC cell lines
Results of immunohistochemical staining against a5
prompted us to investigate its expression on bladder cancer
cell lines and the transitional cell line. Flow cytometric
analyses showed a5 molecules on T24 and HT1376, which are
TCC cell lines with malignant phenotype, and SCaBER,
which is a bladder SCC cell line, but not on RT4 derived
from benign papilloma. However, HTB160, which is a
normal TCC line, showed the presence of a5. All of them
showed positive staining against P1 (Figure 2).
Detection of a5 mRNA by RT-PCR
To confirm the presence of aS mRNA, we performed nested
RT-PCR using two sets of primers. Integrin ac5 cDNA
fragments of the expected size could be amplified from T24,
SCaBER, HT1376 and HTB160 mRNA. However, RT-PCR
for RT4 mRNA did not show any bands (Figure 3).
Discussion
In order to investigate the alteration of integrin expression of
TCC, we immunohistochemically examined al, a2, a3, a4, a5
and /B1 integrin on bladder TCC as well as normal
transitional epithelium. When normal transitional cell
epithelium was stained with the panel of MAbs, only a2, oc3
and /11 were positive. On the other hand, some TCCs
expressed a1, a4 and a5, and these altered expressions of
integrins were observed relatively frequently in the higher
grade and/or stage tumours. These results suggest that
increased expression of al, a4 and a5 might change the
character of TCC to ECM and facilitate tumour invasion or
metastasis. Also, a significant correlation was found only
between increased a5 expression and the histological stage.
Leibert et al. (1994) also showed that a5 integrin was
expressed on high-stage TCC but not on low-stage tumours.
However, a5 was detected on TCC in a rather smaller
number of tumours than in the present study, and there was
no positive staining of a4. These discrepancies may be
explained by the difference in staining methods and/or MAbs
used. We might use a possibly more sensitive staining
procedure, amplifying positive staining by the streptavidin-
biotin system, which we used in other studies (Tomita et al.,
1990, 1993).
A member of the integrin /1 subfamily, VLA-5 (a5fll), is
a fibronectin receptor, and its expression is often reduced in
tumour cells (Plantefaber and Hynes, 1989). In addition,
increase in a5#1 expression by gene transfection decreases
the formation of tumours on Chinese hamster ovary cells,
suggesting that the presence of VLA-5 on cells might be a
disadvantage for tumour cell proliferation by transducing
growth-inhibitory stimuli from fibronectin (Schreiner et al.,
1991). Indeed, after transfection, they showed less migration
and reacquired the features of normal growth control in
culture, resulting in loss of the ability to form tumours
when injected subcutaneously into nude mice (Giancotti and
Ruoslahti, 1990). Several other studies, including human
tumour cells, have confirmed the correlation between low
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Figure 2 Flow cytometric analysis for aS and ,31 chain expression on human TCC cell lines and transitional cell line. Both
expressions were examined on T24, HT1376, SCaBER, RT4 and HTBI60. RT4 did not express a5 integrin.
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Figure 3 Detection of a5 mRNA by nested RT-PCR. (a) RT-
PCR analysis of aS mRNA. T24 (lane 5), HT1376 (lane 4),
SCaBER (lane 3) and HTB160 (lane 1) were positive. RT4 (lane
2) was negative. M, marker. (b) Nested PCR. T24 (lane 5),
HT1376 (lane 4), SCaBER (lane 3) and HTBI60 (lane 1) were
positive. RT4 (lane 2) was negative.
of normal transitional cells showed no ae5 staining.
Compatible with the results of immunohistochemistry on
TCC, flow cytometric analysis on cultured bladder cancer cell
lines showed that T24, SCaBER and HT1376, which are
undifferentiated TCC or SCC cell lines said to have a higher
malignant character, revealed high expression of a5 and ,B1,
whereas RT4, which is derived from transitional cell
papilloma and preserves a well-differentiated character,
showed no expression of a5. SCC of the urinary bladder is
recognised as the most malignant phenotype after metaplasia
of transitional epithelium. Furthermore, RT-PCR showed
the presence of mRNA on T24, SCaBER and HT1376, but
not on RT4. Taken together, it seems more likely that, as for
TCC, the presence of VLA-5 might be a more malignant
phenotype. There have been some reports of the presence of
VLA-5 with malignant phenotype as in the present study
(Terpe et al., 1993; Leibert et al., 1994). Interestingly,
HTB160, which is a normal TCC line, showed positive
staining against a5. However, HTB160 was developed from
fetal bladder. It is possible that the expression of integrin is
different between adult and fetal bladder because its
expression is reported to be different between adult and
fetal kidney (Korhonen et al., 1990).
In conclusion, we have shown the significance of the
expression of integrins on bladder transitional cell cancer,
especially the correlation between VLA-5 and malignant
behaviour of TCC cells. Although the functional aspect of
these results are still unclear, integrins, especially VLA-5,
might have important roles in the invasion and metastasis of
transitional cell cancer.
VLA-5 expression and malignant transformation or a
higher malignancy (Varner et al., 1992; Witkowski et al.,
1993).
The present study on TCC, however, showed a more
frequent expression of ocS and ,B1 chain on TCCs of higher
grade and histopathological stage. In addition, examination
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